Affinity DataIC50: 0.25nMAssay Description:SPA uses 125I as energy donor and scintillant-coated beads as energy acceptor. The labeled ligand is captured by the biotinylated Src-SH2 protein imm...More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Aventis Pharma
Curated by ChEMBL
Aventis Pharma
Curated by ChEMBL
Affinity DataIC50: 0.25nMAssay Description:Inhibitory concentration against SH2 domain of human p60 Src tyrosine kinaseMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Aventis Pharma
Curated by ChEMBL
Aventis Pharma
Curated by ChEMBL
Affinity DataIC50: 0.25nMAssay Description:Binding affinity for Src SH2 domain in scintillation proximity binding assay (SPA)More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Aventis Pharma
Curated by ChEMBL
Aventis Pharma
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Binding affinity for Src protein tryrosine kinase SH2 domain using surface plasmon resonance (SPR) assayMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Aventis Pharma
Curated by ChEMBL
Aventis Pharma
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Binding affinity for Src protein tryrosine kinase SH2 domain using surface plasmon resonance (SPR) assayMore data for this Ligand-Target Pair
Affinity DataIC50: 3nMAssay Description:SPA uses 125I as energy donor and scintillant-coated beads as energy acceptor. The labeled ligand is captured by the biotinylated Src-SH2 protein imm...More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Aventis Pharma
Curated by ChEMBL
Aventis Pharma
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Inhibitory concentration against SH2 domain of human p60 Src tyrosine kinaseMore data for this Ligand-Target Pair
Affinity DataIC50: 4nMAssay Description:SPA uses 125I as energy donor and scintillant-coated beads as energy acceptor. The labeled ligand is captured by the biotinylated Src-SH2 protein imm...More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Aventis Pharma
Curated by ChEMBL
Aventis Pharma
Curated by ChEMBL
Affinity DataIC50: 5nMAssay Description:Binding affinity towards Src protein tryrosine kinase SH2 domain using scintillation proximity binding assay (SPA)More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Aventis Pharma
Curated by ChEMBL
Aventis Pharma
Curated by ChEMBL
Affinity DataIC50: 5nMAssay Description:Inhibitory concentration against SH2 domain of human p60 Src tyrosine kinaseMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Aventis Pharma
Curated by ChEMBL
Aventis Pharma
Curated by ChEMBL
Affinity DataIC50: 7nMAssay Description:Binding affinity towards Src protein tryrosine kinase SH2 domain using surface plasmon resonance (SPR) assayMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Aventis Pharma
Curated by ChEMBL
Aventis Pharma
Curated by ChEMBL
Affinity DataIC50: 9nMAssay Description:Inhibitory concentration against SH2 domain of human p60 Src tyrosine kinaseMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Aventis Pharma
Curated by ChEMBL
Aventis Pharma
Curated by ChEMBL
Affinity DataIC50: 9nMAssay Description:Binding affinity for Src SH2 domain in scintillation proximity binding assay (SPA)More data for this Ligand-Target Pair
Affinity DataIC50: 9nMAssay Description:SPA uses 125I as energy donor and scintillant-coated beads as energy acceptor. The labeled ligand is captured by the biotinylated Src-SH2 protein imm...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:SPA uses 125I as energy donor and scintillant-coated beads as energy acceptor. The labeled ligand is captured by the biotinylated Src-SH2 protein imm...More data for this Ligand-Target Pair
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: 22.9nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: 23nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: 50nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: 50.1nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: 52.5nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: 53nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: 60nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: 60nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: 60.3nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: 60.3nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: 64.6nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: 65nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: 79.4nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: 80nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: 89.1nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Aventis Pharma
Curated by ChEMBL
Aventis Pharma
Curated by ChEMBL
Affinity DataIC50: 90nMAssay Description:Binding affinity was determined on Src protein tryrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solutionMore data for this Ligand-Target Pair
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: 90nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
Affinity DataIC50: 120nMAssay Description:SPA uses 125I as energy donor and scintillant-coated beads as energy acceptor. The labeled ligand is captured by the biotinylated Src-SH2 protein imm...More data for this Ligand-Target Pair
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: 120nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: 120nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Aventis Pharma
Curated by ChEMBL
Aventis Pharma
Curated by ChEMBL
Affinity DataIC50: 130nMAssay Description:Binding affinity was determined on Src protein tryrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solutionMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Aventis Pharma
Curated by ChEMBL
Aventis Pharma
Curated by ChEMBL
Affinity DataIC50: 143nMAssay Description:Inhibitory concentration against SH2 domain of human p60 Src tyrosine kinaseMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Aventis Pharma
Curated by ChEMBL
Aventis Pharma
Curated by ChEMBL
Affinity DataIC50: 150nMAssay Description:Binding affinity was determined on Src protein tryrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solutionMore data for this Ligand-Target Pair
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: 150nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: 150nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: 151nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: 151nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: 158nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: 158nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: 158nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: 160nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: 160nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: 160nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: 190nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: 191nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair